The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. As an entrepreneurial specialist, we have many years’ experience in innovative pain therapy and developing state-of-the-art technology that makes our patients’ day-to-day lives significantly easier.
Our priority is always the health and wellbeing of our patients. This is demonstrated by our investment in research and development, which is way above the industry average – in 2016, for example, it came to around 20% of our annual revenue.
Further information can be found in our company presentation.